In this issue:
Beta-blocker interruption vs continuation after MI
Finerenone in patients with HFpEF
Early vs delayed coronary angiography in NSTEMI
Semaglutide efficacy in patients with obesity-related HFpEF and AF
Workplace sexual harassment and risk of cardiometabolic diseases
Long-term outcomes after stress echocardiography in real world practice
Efficacy of semaglutide in patients with obesity and chronic kidney disease
Partial cardiac denervation to prevent postoperative AF after CAGS
Efficacy of finerenone in females vs males with HFpEF
Impact of smoking cessation on incident AF risk
Please login below to download this issue (PDF)